News

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in adults with severe mental illness, as well as having positive effects on ...
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in ...
The study showed that Glucagon-like peptide-1 (GLP-1) analogues — drugs developed to treat obesity — likely curb alcohol ...
Anup Mishra, Chairman, Fortis, CDOC Hospital for Diabetes, and Allied Sciences, Chandrakanth Lahariya, Health and Social Sector Policy Advisor, Preetha Reddy, Executive Vice Chairperson, Apollo ...
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in adults with severe mental ...
Fatty liver disease, also called metabolic dysfunction-associated steatohepatitis (MASH), is a condition where fat ...
New research presented at the European Congress on Obesity (ECO 2025) and published in the journal Diabetes, Obesity and ...
Research presented at the the European Congress on Obesity suggests weight loss injections are safe and work for the mentally ...